In recent years, ketamine has transformed from an anesthetic to one of the most promising treatments being studied for depression.
Join Robert C. Meisner, MD, Harvard-affiliated psychiatrist and medical director of McLean’s Ketamine Service, for this free, 60-minute session exploring what we know—and what we’re learning—about ketamine in psychiatric care.
Why This Training Matters
Treatment-resistant depression affects millions, and for some, traditional medications don’t work.
Ketamine has changed that conversation. But myths, misinformation, and uneven access can leave patients and providers uncertain about where it fits in the treatment landscape.
Dr. Meisner explains the science behind ketamine’s rapid antidepressant effects, the difference between infusion and esketamine approaches, and how clinicians and patients can identify ethical, effective care.
What You’ll Learn
Why ketamine is being explored as a treatment for depression
How ketamine works in the brain and what its mechanisms reveal about mood regulation
The similarities and differences between IV infusion and esketamine nasal spray
The benefits, limitations, and safety considerations of ketamine therapy
How to identify legitimate providers and avoid misinformation
What to expect from treatment protocols and outcomes
What the term “psychedelic” really means in clinical context
How ketamine fits within a broader continuum of depression treatment options
Who Should Attend
Mental health professionals (psychologists, psychiatrists, social workers, nurses, counselors, and therapists)
Pediatricians and primary-care providers
K-12 and university educators and school staff
Public health professionals
Parents and caregivers
Community and faith leaders
Executives, managers, and HR professionals
Event Details
Date: January 7, 2026
Time: 12pm ET
Length: 60 minutes
Presenter: Robert C. Meisner, MD
Cost: Free
Join this free, expert-led session to gain clarity on the science, safety, and real-world outcomes of ketamine as a treatment for depression.
Can’t join our session live? Sign up anyway! You’ll receive a recording by email a few days after the webinar.